The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Signal Transduction
The EMBO Journal (2006) 25, 5683–5692, doi:10.1038/sj.emboj.7601457
Published online 30 November 2006
p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration
Mark R Frey1, Rebecca S Dise2, Karen L Edelblum2 and D Brent Polk1, 2
1 Division of Gastroenterology, Hepatology & Nutrition, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA
2 Department of Cell & Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA

To whom correspondence should be addressed
D Brent Polk, Division of Gastroenterology, Hepatology & Nutrition, Department of Pediatrics, Vanderbilt University Medical Center, MRB IV Room 1025, 2215 Garland Avenue, Nashville, TN 37232-0696, USA. Tel.: +1 615 322 7449; Fax: +1 615 343 5323; E-mail: d-brent.polk@vanderbilt.edu

Received 8 May 2006; Accepted 27 October 2006; Published online 30 November 2006.
Abstract
Internalization and proteolytic degradation of epidermal growth factor (EGF) receptor (R) following ligand binding is an important mechanism for regulating EGF-stimulated signals. Using pharmacological and RNA interference inhibition of p38 mitogen-activated protein kinase, we show that p38 is required for efficient EGF-induced EGFR destruction but not internalization. In the absence of p38 activity, EGF fails to stimulate the ubiquitin ligase Cbl or ubiquitinylation of EGFR, and internalized EGFR accumulates in intracellular vesicles containing caveolin-1. These effects are accompanied by loss of EGFR phosphorylation on Y1045, a phosphorylation site required for Cbl activation. Furthermore, similar to cells treated with p38 inhibitors, intestinal epithelial cells expressing Y1045F EGFR mutants show increased proliferation but not migration in response to EGF, thus uncoupling these biological responses. Together these data position p38 as a modulator of ligand-stimulated EGFR processing and demonstrate that this processing has a profound impact on the cellular outcome of EGFR signaling.
Keywords: EGF receptor, intestinal epithelium, p38 MAPK, ubiquitinylation, wound healing
Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization